Drugs / Antimoniate of N-methylglucamine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01310738 | Feb 2011 → Oct 2014 | visceral leishmaniasis | University of Brasilia | Terminated | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Antimoniate of N-methylglucamine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01310738 ↗ |
| Route | Intravenous | “Antimoniate of N-methyl glucamine 20mg/kg/d of pentavalent antimonial, I.V. for 20 consecutive days.” NCT01310738 ↗ |